Cargando…

Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer

BACKGROUND: To date, no combined immunoscore has been evaluated for prognostic stratification of early stage non-small-cell lung cancer (NSCLC). The main goal of this study was to investigate the prognostic impact of programmed death ligand 1 (PD-L1) expression and different immune cell components (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boscolo, Alice, Fortarezza, Francesco, Lunardi, Francesca, Comacchio, Giovanni, Urso, Loredana, Frega, Stefano, Menis, Jessica, Bonanno, Laura, Guarneri, Valentina, Rea, Federico, Conte, PierFranco, Calabrese, Fiorella, Pasello, Giulia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544833/ https://www.ncbi.nlm.nih.gov/pubmed/33072595 http://dx.doi.org/10.3389/fonc.2020.564915

Ejemplares similares

Tumor Immune-Infiltrate Landscape After Chemo-Radiotherapy in a Case Series of Patients with Non-small Cell Lung Cancer: Pretreatment Predictors and Correlation With Outcome
por: Pavan, Alberto, et al.
Publicado: (2022)

Lung Cancer (LC) in HIV Positive Patients: Pathogenic Features and Implications for Treatment
por: Frega, Stefano, et al.
Publicado: (2020)

Diagnostic-Therapeutic Pathway and Outcomes of Early Stage NSCLC: a Focus on EGFR Testing in the Real-World
por: Pasello, Giulia, et al.
Publicado: (2022)

Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations
por: Frega, Stefano, et al.
Publicado: (2017)

The Rarest of Rare Thymic Lesions: A 10-Year Surgical Pathology Experience
por: Calabrese, Fiorella, et al.
Publicado: (2021)

MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: correlation with pathological and clinical data
por: Pasello, Giulia, et al.
Publicado: (2015)

Novel Nuclear Medicine Imaging Applications in Immuno-Oncology
por: Frega, Stefano, et al.
Publicado: (2020)

How the COVID-19 Pandemic Impacted on Integrated Care Pathways for Lung Cancer: The Parallel Experience of a COVID-Spared and a COVID-Dedicated Center
por: Pasello, Giulia, et al.
Publicado: (2021)

Diagnostic Challenges in Epithelioid Pleural Mesothelioma: Case Series with Support from Electron Microscopy
por: Fortarezza, Francesco, et al.
Publicado: (2021)

Subacute Cutaneous Lupus Erythematosus-Like Eruption Induced by EGFR -Tyrosine Kinase Inhibitor in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report
por: Ferro, Alessandra, et al.
Publicado: (2021)

Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome
por: Pavan, Alberto, et al.
Publicado: (2021)

P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment
por: Pezzuto, Federica, et al.
Publicado: (2021)

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature
por: Polo, Valentina, et al.
Publicado: (2015)

The Multidisciplinary Approach in Stage III Non-Small Cell Lung Cancer over Ten Years: From Radiation Therapy Optimisation to Innovative Systemic Treatments
por: Ferro, Alessandra, et al.
Publicado: (2022)

Squamous cell carcinomas of the lung and of the head and neck: new insights on molecular characterization
por: Polo, Valentina, et al.
Publicado: (2016)

Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer
por: Zulato, Elisabetta, et al.
Publicado: (2020)

Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg?
por: Bonanno, Laura, et al.
Publicado: (2022)

Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists
por: Urso, Loredana, et al.
Publicado: (2017)

Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors
por: Zulato, Elisabetta, et al.
Publicado: (2022)

LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer
por: Bonanno, Laura, et al.
Publicado: (2019)

Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment
por: Bonanno, Laura, et al.
Publicado: (2016)

Morphologic-Molecular Transformation of Oncogene Addicted Non-Small Cell Lung Cancer
por: Calabrese, Fiorella, et al.
Publicado: (2022)

Evaluation of Tissue Ischemia/Reperfusion Injury in Lung Recipients Supported by Intraoperative Extracorporeal Membrane Oxygenation: A Single-Center Pilot Study
por: Calabrese, Fiorella, et al.
Publicado: (2022)

Intrathymic Localization of Melanoma: A Brief Report of Two Cases and a Review of the Literature
por: Cannone, Giorgio, et al.
Publicado: (2023)

First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study
por: Lorenzi, Martina, et al.
Publicado: (2021)

Comprehensive bronchoalveolar lavage characterization in COVID-19 associated acute respiratory distress syndrome patients: a prospective cohort study
por: Calabrese, Fiorella, et al.
Publicado: (2023)

Relapse Patterns and Tailored Treatment Strategies for Malignant Pleural Mesothelioma Recurrence after Multimodality Therapy
por: Bellini, Alice, et al.
Publicado: (2021)

Estimated direct costs of non‐small cell lung cancer by stage at diagnosis and disease management phase: A whole‐disease model
por: Buja, Alessandra, et al.
Publicado: (2020)

Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges
por: Pavan, A., et al.
Publicado: (2019)

Precision Surgery in NSCLC
por: Cannone, Giorgio, et al.
Publicado: (2023)

Molecular Profiling of Tissue Samples with Chronic Rejection from Patients with Chronic Lung Allograft Dysfunction: A Pilot Study in Cystic Fibrosis Patients
por: Lunardi, Francesca, et al.
Publicado: (2023)

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?
por: Calabrese, Fiorella, et al.
Publicado: (2019)

Microscopical Variables and Tumor Inflammatory Microenvironment Do Not Modify Survival or Recurrence in Stage I-IIA Lung Adenocarcinomas
por: Dell’Amore, Andrea, et al.
Publicado: (2023)

Immunotherapy in malignant pleural mesothelioma: a review of literature data
por: Menis, Jessica, et al.
Publicado: (2021)

Short- and Long-Term Impact of Smoking Donors in Lung Transplantation: Clinical and Pathological Analysis
por: Schiavon, Marco, et al.
Publicado: (2021)

A Complex Case of Pulmonary Silico-Tuberculosis and Review of Literature
por: D’Sa, Lauren, et al.
Publicado: (2023)

Liquid Biopsy in Malignant Pleural Mesothelioma: State of the Art, Pitfalls, and Perspectives
por: Cavallari, Ilaria, et al.
Publicado: (2019)

Two Sorts of Microthrombi in a Patient With Coronavirus Disease 2019 and Lung Cancer
por: Calabrese, Fiorella, et al.
Publicado: (2020)

Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab
por: Pasello, Giulia, et al.
Publicado: (2022)

Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia
por: Lunardi, Francesca, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_99j8f69ocojs6ls473m2in94e8